plerixafor has been researched along with Endometriosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gaye, M; Habata, S; Mamillapalli, R; Pluchino, N; Shaikh, S; Tal, A; Taylor, HS | 1 |
| Bayona, M; Colón-Caraballo, M; Fazleabas, AT; Flores, I; Monteiro, JB; Ruiz, A; Ruiz, L; Torres-Collazo, BJ | 1 |
| Giebels, C; Laschke, MW; Menger, MD; Nickels, RM; Scheuer, C | 1 |
3 other study(ies) available for plerixafor and Endometriosis
| Article | Year |
|---|---|
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Topics: Adult Stem Cells; Animals; Benzylamines; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Cyclams; Endometriosis; Endometrium; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Uterus | 2020 |
Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion.
Topics: Anti-HIV Agents; Benzylamines; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Endometriosis; Endometrium; Female; Gene Expression Regulation; Heterocyclic Compounds; Humans; Immunohistochemistry; Receptors, CXCR4; Tissue Culture Techniques | 2018 |
Endothelial progenitor cells contribute to the vascularization of endometriotic lesions.
Topics: Animals; Antigens, Ly; Benzylamines; Cyclams; Endometriosis; Endothelium, Vascular; Female; Green Fluorescent Proteins; Heterocyclic Compounds; Membrane Proteins; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2011 |